Tompkins Financial’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-840
Closed -$20.5K 611
2024
Q2
$20.5K Hold
840
﹤0.01% 432
2024
Q1
$17.9K Hold
840
﹤0.01% 445
2023
Q4
$16.1K Buy
+840
New +$16.1K ﹤0.01% 444